These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1467578)

  • 21. Quality of clinical MR images and the use of contrast agents.
    Creasy JL; Partain CL; Price RR
    Radiographics; 1995 May; 15(3):683-96. PubMed ID: 7624572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-enhanced MR imaging of neurocutaneous melanosis.
    Rhodes RE; Friedman HS; Hatten HP; Hockenberger B; Oakes WJ; Tomita T
    AJNR Am J Neuroradiol; 1991; 12(2):380-2. PubMed ID: 1902050
    [No Abstract]   [Full Text] [Related]  

  • 23. Basic principles of MR contrast.
    Nelson KL; Runge VM
    Top Magn Reson Imaging; 1995; 7(3):124-36. PubMed ID: 7654392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR cisternography and myelography with Gd-DTPA in monkeys.
    Di Chiro G; Knop RH; Girton ME; Dwyer AJ; Doppman JL; Patronas NJ; Gansow OA; Brechbiel MW; Brooks RA
    Radiology; 1985 Nov; 157(2):373-7. PubMed ID: 4048444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical applications of FLAIR, HASTE, and magnetization transfer in neuroimaging.
    Castillo M; Mukherji SK
    Semin Ultrasound CT MR; 2000 Dec; 21(6):417-27. PubMed ID: 11138631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pitfalls of contrast-enhanced imaging in the nervous system.
    Brant-Zawadzki M
    Magn Reson Med; 1991 Dec; 22(2):243-8. PubMed ID: 1812353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with gadodiamide injection in magnetic resonance imaging of the central nervous system.
    Andrew E; Svaland M; Lundby B; Hugo F; LaFrance N
    Invest Radiol; 1994 Jun; 29 Suppl 2():S186-8. PubMed ID: 7928225
    [No Abstract]   [Full Text] [Related]  

  • 28. Contrast enhancement issues in the MR evaluation of the central nervous system.
    Colosimo C; Manfredi R; Tartaglione T
    Eur Radiol; 1997; 7 Suppl 5():231-7. PubMed ID: 9370549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging of the central nervous system in children with a new nonionic gadolinium contrast agent--gadoteridol injection (ProHance).
    Byrd SE; Darling CF; Wilczynski MA
    J Natl Med Assoc; 1993 May; 85(5):361-6. PubMed ID: 8496990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of neuroimaging to guide the histologic diagnosis of central nervous system lesions.
    Vincentelli C; Hwang SN; Holder CA; Brat DJ
    Adv Anat Pathol; 2012 Mar; 19(2):97-107. PubMed ID: 22313837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system: review of clinical use of contrast media.
    Runge VM; Muroff LR; Jinkins JR
    Top Magn Reson Imaging; 2001 Aug; 12(4):231-63. PubMed ID: 11687713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of paramagnetic contrast agents and the spin echo pulse sequence.
    Joseph PM
    Invest Radiol; 1989 Jun; 24(6):508-9. PubMed ID: 2562496
    [No Abstract]   [Full Text] [Related]  

  • 33. Preliminary evaluation: magnetic resonance of urography using a saturation inversion projection spin-echo sequence.
    Schad LR; Semmler W; Knopp MV; Deimling M; Weinmann HJ; Lorenz WJ
    Magn Reson Imaging; 1993; 11(3):319-27. PubMed ID: 8505865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in contrast-enhanced MR imaging. Neurologic applications.
    Modic MT
    AJR Am J Roentgenol; 1991 Feb; 156(2):239-45. PubMed ID: 1898793
    [No Abstract]   [Full Text] [Related]  

  • 35. High-field MRI of the central nervous system: current approaches to clinical and microscopic imaging.
    Sasaki M; Inoue T; Tohyama K; Oikawa H; Ehara S; Ogawa A
    Magn Reson Med Sci; 2003 Oct; 2(3):133-9. PubMed ID: 16222104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of magnetic resonance tomography in studying the central nervous system].
    Tiutin LA; Rokhlin GD; Dyskin EA; Neronov IuI
    Morfologiia; 1994; 106(4-6):165-8. PubMed ID: 8718651
    [No Abstract]   [Full Text] [Related]  

  • 37. III. New developments: 2. Virtual MR endoscopy in the central nervous system.
    Shigematsu Y; Korogi Y; Hirai T; Okuda T; Sugahara T; Liang L; Ge Y; Takahashi M
    J Magn Reson Imaging; 1998; 8(2):289-96. PubMed ID: 9562055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technical note: reducing motion artifacts in in vivo magnetic resonance imaging measurements of relaxation times.
    Gowland PA; Leach MO; Tanner SF
    Br J Radiol; 1994 Dec; 67(804):1249-57. PubMed ID: 7874426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadolinium-Free Contrast Agents for Magnetic Resonance Imaging of the Central Nervous System.
    Gale EM; Caravan P
    ACS Chem Neurosci; 2018 Mar; 9(3):395-397. PubMed ID: 29431424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in pediatric neuroimaging.
    Zimmerman RA; Haselgrove JC; Wang Z; Hunter JV; Morriss MC; Hoydu A; Bilaniuk LT
    Brain Dev; 1998 Aug; 20(5):275-89. PubMed ID: 9760996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.